Predicting individual responses to pravastatin using a physiologically based kinetic model for plasma cholesterol...

Area of Science:

• Pharmacokinetics and Pharmacodynamics
• Systems Biology
• Cholesterol Metabolism

Background:

• Individual responses to statins like pravastatin vary significantly.
• Understanding the mechanisms of cholesterol metabolism is key to personalized medicine.

Purpose of the Study:

• To develop and validate a physiologically based kinetic (PBK) model to analyze individual variations in cholesterol metabolism and transport.
• To investigate the impact of these variations on pravastatin response.
• To predict plasma cholesterol concentrations based on pravastatin dosage.

Main Methods:

• A previously developed PBK model of cholesterol metabolism was integrated with a pravastatin pharmacokinetic model.
• Simulated hepatic pravastatin concentration modulated hepatic free cholesterol synthesis.
• A virtual population of 7,609 subjects was generated using Monte Carlo simulation for dose-response analysis.

Main Results:

• The integrated model accurately predicted reductions in total plasma cholesterol and increases in HDL cholesterol.
• Linear regression identified hepatic and peripheral cholesterol synthesis as significant factors for non-HDL-C response.
• However, these factors alone were insufficient to predict non-HDL-C response, challenging existing hypotheses.

Conclusions:

• A validated PBK model can accurately describe pravastatin's effect on plasma cholesterol.
• The model provides insights into the complex mechanisms underlying individual variations in statin response.
• High cholesterol synthesis rates do not solely determine a patient's response to pravastatin.